No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
CA Stock MarketDetailed Quotes
LABS MediPharm Labs Corp
- 0.060
- 0.0000.00%
15min DelayMarket Closed Dec 31 16:00 ET
24.67MMarket Cap-2.00P/E (TTM)
0.065High0.060Low196.91KVolume0.060Open0.060Pre Close11.82KTurnover0.10052wk High0.05%Turnover Ratio411.12MShares0.06052wk Low-0.03EPS TTM22.74MFloat Cap7.390Historical HighLossP/E (Static)379.07MShs Float0.055Historical Low-0.04EPS LYR8.33%Amplitude--Dividend TTM0.55P/B1Lot Size--Div YieldTTM
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
MediPharm Labs Sells Napanee Facility to Kensana Health for $5.5 Million; Shares at 52 Week Lows
MediPharm Labs Brief: Selling Its Napanee Facility to Kensana Health for $5.5 Million
MediPharm Labs Brief: Net Revenue $9.8 Million in Q3 2024, a 15% Increase as Compared to Q3 2023; Cites Strong Growth in International GMP Medical Markets
MediPharm Labs Corp. Brief: Announcing Departure of President and Co-Founder Keith Strachan
MediPharm Labs "Materially" Debt-Free After $2.1 Million Debt Payment
MediPharm Labs Corp. (MEDIF) Q2 2024 Earnings Call Transcript Summary
Heat List
CA
Overall
Symbol
Price
% Chg
No Data